176 related articles for article (PubMed ID: 26405024)
21. Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
J Rheumatol; 2011 Jul; 38(7):1289-95. PubMed ID: 21459949
[TBL] [Abstract][Full Text] [Related]
22. Clinical analysis of systemic lupus erythematosus with gastrointestinal manifestations.
Xu D; Yang H; Lai CC; Li P; Zhang X; Yang XO; Zhang FC; Qian JM
Lupus; 2010 Jun; 19(7):866-9. PubMed ID: 20410154
[TBL] [Abstract][Full Text] [Related]
23. Long term follow-up of patients with systemic lupus erythematosus.
Xie SK; Feng SF; Fu H
J Dermatol; 1998 Jun; 25(6):367-73. PubMed ID: 9675343
[TBL] [Abstract][Full Text] [Related]
24. Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.
Souza DC; Santo AH; Sato EI
J Rheumatol; 2012 Mar; 39(3):496-503. PubMed ID: 22247362
[TBL] [Abstract][Full Text] [Related]
25. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study.
Hassan AA; Habib HM; Eissa AA
Int J Rheum Dis; 2013 Jun; 16(3):319-24. PubMed ID: 23981754
[TBL] [Abstract][Full Text] [Related]
26. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
Maksimowicz-McKinnon K; Magder LS; Petri M
J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
[TBL] [Abstract][Full Text] [Related]
28. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.
Calvo-Alen J; Alarcon GS; Burgard SL; Burst N; Bartolucci AA; Williams HJ
J Rheumatol; 1996 Mar; 23(3):469-75. PubMed ID: 8832985
[TBL] [Abstract][Full Text] [Related]
29. Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus.
Khairullah S; Jasmin R; Yahya F; Cheah TE; Ng CT; Sockalingam S
Lupus; 2013 Aug; 22(9):957-60. PubMed ID: 23761180
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study.
Abdul-Sattar AB; Goda T; Negm MG
Int J Rheum Dis; 2013 Dec; 16(6):715-23. PubMed ID: 24382281
[TBL] [Abstract][Full Text] [Related]
31. The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
Compagno M; Gullstrand B; Jacobsen S; Eilertsen GØ; Nilsson JÅ; Lood C; Jönsen A; Truedsson L; Sturfelt G; Bengtsson AA
Arthritis Res Ther; 2016 Feb; 18():44. PubMed ID: 26860519
[TBL] [Abstract][Full Text] [Related]
32. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.
Pamuk ON; Akbay FG; Dönmez S; Yilmaz N; Calayir GB; Yavuz S
Lupus; 2013 Nov; 22(13):1416-24. PubMed ID: 23929639
[TBL] [Abstract][Full Text] [Related]
33. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.
Li M; Wang Q; Zhao J; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian Z; Liu Y; He J; Zhang F; Zhao Y; Zeng X;
Lupus; 2014 Sep; 23(10):1085-91. PubMed ID: 24651670
[TBL] [Abstract][Full Text] [Related]
34. Major gastrointestinal manifestations in lupus patients in Asia: lupus enteritis, intestinal pseudo-obstruction, and protein-losing gastroenteropathy.
Chng HH; Tan BE; Teh CL; Lian TY
Lupus; 2010 Oct; 19(12):1404-13. PubMed ID: 20947549
[TBL] [Abstract][Full Text] [Related]
35. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
[TBL] [Abstract][Full Text] [Related]
36. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Mejía JC; Aydintug AO; Chwalinska-Sadowska H; de Ramón E; Fernández-Nebro A; Galeazzi M; Valen M; Mathieu A; Houssiau F; Caro N; Alba P; Ramos-Casals M; Ingelmo M; Hughes GR;
Medicine (Baltimore); 2003 Sep; 82(5):299-308. PubMed ID: 14530779
[TBL] [Abstract][Full Text] [Related]
37. Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE.
Cheng Y; Li M; Zhao J; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Huang C; Zeng X;
Int J Rheum Dis; 2018 Mar; 21(3):716-724. PubMed ID: 28296238
[TBL] [Abstract][Full Text] [Related]
38. The association between initial manifestations of childhood-onset systemic lupus erythematosus and the survival.
Fatemi A; Matinfar M; Saber M; Smiley A
Int J Rheum Dis; 2016 Oct; 19(10):974-980. PubMed ID: 26632491
[TBL] [Abstract][Full Text] [Related]
39. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.
Pamuk ON; Balci MA; Donmez S; Tsokos GC
Lupus; 2016 Jan; 25(1):102-9. PubMed ID: 26345673
[TBL] [Abstract][Full Text] [Related]
40. [Chronic intestinal pseudo-obstruction in systemic lupus erythematosus].
Ghannouchi Jaafoura N; Khalifa M; Atig A; Ben Jazia E; Alaoua A; Braham Krifa A; Letaief A; Bahri F
Rev Med Interne; 2011 Jan; 32(1):e1-3. PubMed ID: 21035926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
